Symbiox Investment & Trading Co Analysis

dividend

Pros

Cons

• Unable to evaluate Symbiox Investment & Trading Co's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
• Unable to evaluate Symbiox Investment & Trading Co's dividend against the top 25% market benchmark as the company has not reported any payouts.

health

Pros

• Symbiox Investment & Trading Co is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
• Symbiox Investment & Trading Co has been profitable on average in the past, therefore cash runway is not a concern.
• Symbiox Investment & Trading Co has been profitable on average in the past, therefore cash runway is not a concern.
• Debt is well covered by operating cash flow (607.8%, greater than 20% of total debt).
• Debt is covered by short term assets, assets are 121.5x debt.
• Symbiox Investment & Trading Co's cash and other short term assets cover its long term commitments.
• Symbiox Investment & Trading Co's level of debt (0.8%) compared to net worth is satisfactory (less than 40%).
• Low level of unsold assets.

Cons

management

Pros

Cons

• The average tenure for the Symbiox Investment & Trading Co board of directors is less than 3 years, this suggests a new board.

misc

Pros

Cons

• Symbiox Investment & Trading Co is not covered by any analysts.
• Symbiox Investment & Trading Co has significant price volatility in the past 3 months.

past

Pros

Cons

• Unable to compare Symbiox Investment & Trading Co's 1-year earnings growth to the 5-year average as it is not currently profitable.
• Symbiox Investment & Trading Co does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
• It is difficult to establish if Symbiox Investment & Trading Co has efficiently used its assets last year compared to the IN Retail Distributors industry average (Return on Assets) as it is loss-making.
• It is difficult to establish if Symbiox Investment & Trading Co improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
• It is difficult to establish if Symbiox Investment & Trading Co has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
• Unable to compare Symbiox Investment & Trading Co's 1-year growth to the IN Retail Distributors industry average as it is not currently profitable.

value

Pros

• Symbiox Investment & Trading Co's share price is below the future cash flow value, and at a moderate discount (> 20%).
• Symbiox Investment & Trading Co's share price is below the future cash flow value, and at a substantial discount (> 40%).
• Symbiox Investment & Trading Co is good value based on assets compared to the IN Retail Distributors industry average.
• BSE:539278 is up 8.3% along with the Retail Distributors industry (7.5%) over the past month.
• BSE:539278 is up 8.3% along with the India market (8%) over the past month.

Cons

• Symbiox Investment & Trading Co is loss making, we can't compare its value to the IN Retail Distributors industry average.
• Symbiox Investment & Trading Co is loss making, we can't compare the value of its earnings to the India market.
• 539278 underperformed the Retail Distributors industry which returned -12% over the past year.
• 539278 underperformed the Market in India which returned -14.5% over the past year.